Surgical and Medical Robots: How Robots Are Transforming Healthcare

How Surgical Robots Work

A surgical robot system has three main components: the surgeon console, the patient-side cart, and the vision system. The surgeon sits at a console, often across the room from the patient, and controls the robot using hand controllers and foot pedals. The patient-side cart holds the robotic arms (typically three to four) that enter the patient's body through small incisions (ports) of 8 to 12 millimeters. A high-definition stereo endoscope provides the surgeon with a magnified 3D view of the surgical site.

The robot translates the surgeon's hand movements into precise instrument movements inside the body. Critically, the system scales motion: a 3-centimeter hand movement at the console might produce a 1-centimeter instrument movement at the surgical site. This scaling, combined with tremor filtering that removes involuntary hand shake, enables precision that exceeds unaided human capability. The instruments at the tip of the robotic arms have "wristed" joints that bend and rotate with more degrees of freedom than the human wrist, allowing manipulation in tight spaces that would be impossible with straight laparoscopic instruments.

Despite the name "robotic surgery," these systems are not autonomous. The surgeon controls every movement. The robot provides mechanical advantages (precision, scaling, tremor filtering, enhanced visualization) but makes no decisions. The correct term is "robot-assisted surgery" rather than "robotic surgery."

The da Vinci Surgical System

Intuitive Surgical's da Vinci system dominates the surgical robotics market with approximately 9,000 systems installed in hospitals worldwide. The current generation, the da Vinci 5 (launched in 2024), features force feedback that lets the surgeon feel tissue resistance through the hand controllers, a significant advancement over previous generations that provided only visual cues. The system costs approximately $1.5 to $2.5 million to purchase, with annual maintenance costs of $150,000 to $200,000 and per-procedure instrument costs of $700 to $3,500.

The most common da Vinci procedures include prostatectomy (prostate removal, where robot-assisted surgery has become the standard of care in the US), hysterectomy, lung lobectomy, colorectal surgery, cardiac valve repair, and kidney surgery. Clinical evidence generally shows that robot-assisted surgery provides comparable oncological outcomes (cancer cure rates) to open surgery, with reduced blood loss, shorter hospital stays, faster recovery, and lower rates of certain complications. The evidence varies by procedure type, and for some operations, the clinical benefit of the robot over standard laparoscopic surgery remains debated.

Other Surgical Robot Systems

The da Vinci's near-monopoly is being challenged by several competitors entering the market with newer technology and lower price points.

Medtronic Hugo RAS is a modular system that uses separate arm carts (rather than a single multi-arm cart) for more flexible positioning around the operating table. Hugo uses an open console design that allows the surgeon to look up and communicate directly with the surgical team, addressing a common criticism of the enclosed da Vinci console. Hugo received its first regulatory approvals in 2021 and is expanding globally.

CMR Surgical Versius is a lightweight, modular system developed in Cambridge, UK. Each Versius arm is individually mounted on a small cart, giving surgical teams flexibility in how they position the robot around the patient. The system is significantly smaller and less expensive than the da Vinci, targeting hospitals that cannot justify the cost of a full da Vinci installation.

Johnson & Johnson's Ottava is in late-stage development, designed to integrate with J&J's extensive surgical instrument portfolio. Ottava uses six arms (more than the typical four) and a simplified setup process to reduce the time and staffing needed for each robotic case.

Stryker's Mako is the leading orthopedic surgical robot, used for knee and hip replacement. Unlike soft-tissue surgical robots that follow the surgeon's movements in real time, Mako uses pre-operative CT scans to create a 3D model of the patient's joint and plans the precise bone cuts needed for optimal implant placement. During surgery, the robot provides haptic boundaries that prevent the surgeon from cutting beyond the planned area, ensuring accuracy even if the surgeon's hand moves outside the intended zone.

Rehabilitation Robots

Rehabilitation robots help patients recover motor function after strokes, spinal cord injuries, traumatic brain injuries, and orthopedic surgeries. The fundamental principle is repetitive, task-specific practice: performing the same movement hundreds or thousands of times retrains the neural pathways that control that movement.

Upper extremity robots like the MIT-Manus (now marketed as InMotion ARM) guide a patient's arm through reaching and grasping exercises. The robot can assist the movement (helping the patient complete it), resist the movement (making it harder to build strength), or simply measure the patient's unassisted performance for assessment. Clinical trials have shown that robot-assisted upper extremity therapy produces equal or slightly better motor recovery outcomes compared to traditional one-on-one physical therapy, with the added benefit that the robot provides precise, quantitative measurements of patient progress.

Exoskeleton robots for lower extremities enable paralyzed patients to stand and walk. Devices like Ekso Bionics' EksoNR and ReWalk's systems strap onto the patient's legs and use motors at the hip and knee joints to produce a walking gait. Sensors detect the patient's intended movements (through residual muscle signals, weight shifts, or upper body gestures) and the exoskeleton provides the force needed to execute the step. Beyond motor recovery, exoskeleton walking provides cardiovascular benefits, reduces secondary complications of immobility (pressure sores, bone density loss, urinary tract infections), and improves psychological well-being.

Gait training robots like the Lokomat support the patient's body weight on a treadmill while robotic leg orthoses guide the limbs through a walking pattern. By supporting a portion of the patient's body weight (adjustable from 0% to 100%), the robot allows patients to practice walking before they have the strength to support themselves fully. As the patient improves, the robot reduces assistance, progressively challenging the patient to do more of the work.

Pharmacy and Hospital Robots

Pharmacy automation systems store, sort, count, and dispense medications with near-zero error rates. A typical hospital pharmacy robot handles 500 to 2,000 dispensing operations per day, verifying each medication against the prescription using barcode scanning. These systems reduce medication errors (a leading cause of preventable harm in hospitals) by eliminating the human steps where errors most commonly occur: reading handwriting, picking the correct bottle from a shelf of similar-looking medications, and counting tablets.

Hospital delivery robots transport medications, lab specimens, sterile supplies, and linens through hospital corridors. Robots from Aethon (TUG), Swisslog, and Savioke navigate autonomously using maps and onboard sensors, calling elevators, opening doors (via integration with building management systems), and navigating around staff and patients. These robots free nurses and support staff from delivery tasks, allowing them to spend more time on patient care.

Disinfection robots use ultraviolet-C (UV-C) light to kill bacteria, viruses, and other pathogens on surfaces in patient rooms and operating theaters. The robot autonomously navigates the room, positioning its UV-C lamps to ensure adequate radiation exposure on all surfaces. UV-C disinfection robots gained widespread adoption during the COVID-19 pandemic and have remained in use as hospitals recognized their effectiveness in reducing healthcare-associated infections.

Telepresence and Diagnostic Robots

Telepresence robots allow physicians to virtually visit patients remotely. The robot, essentially a screen on a mobile base, drives to the patient's bedside under the physician's control. The doctor sees and hears the patient through the robot's cameras and microphones, and the patient sees the doctor's face on the screen. InTouch Health (now part of Teladoc) pioneered this category, and telepresence robots are now standard in many hospitals, particularly for after-hours specialist consultations in rural and underserved facilities.

Diagnostic assistance robots are in earlier stages but advancing rapidly. AI-powered systems can analyze medical images (X-rays, CT scans, pathology slides, retinal photographs) with accuracy comparable to or exceeding that of human specialists for specific conditions. While these are primarily software systems, robotic platforms that autonomously acquire the images (such as robotic ultrasound systems that position and orient the probe automatically) are being developed to bring diagnostic capabilities to settings without trained human operators.

Challenges and Limitations

Cost remains the primary barrier. A da Vinci system costs $1.5 to $2.5 million upfront plus $150,000 or more annually for maintenance and consumables. Many hospitals struggle to justify this investment, particularly when clinical outcomes for some procedures are comparable to conventional techniques. Newer competitors are driving prices down, but robotic surgery remains significantly more expensive than traditional approaches.

Training requirements are substantial. Surgeons must complete extensive training programs (typically 40 to 100 cases under supervision) before independently performing robot-assisted procedures. Training infrastructure, including simulation systems, proctoring programs, and credentialing pathways, adds cost and time.

Autonomy is extremely limited. Unlike industrial robots that can operate independently, surgical robots are entirely dependent on the surgeon's moment-to-moment control. Autonomous surgical actions, such as a robot independently suturing or cutting, are active research topics but are not clinically available. The regulatory pathway for autonomous surgical systems is uncertain and likely to be long.